KOSDAQ · Healthcare · ₩108B
₩5,370+1.90%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.2% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“제약 사업 확장이 새 성장축으로 자리 잡는 중입니다.”
In the company's words · 2026 2분기 filing